White Mountains adds Stephen Klar to board of directors

White Mountains Insurance (WTM) reported Q2 2026 results with book value per share up 4% to $2,258. Net income rose to $199.5M from $122.9M YoY. Ark segment had an 84% combined ratio, indicating profitable underwriting. The company repurchased shares below book value, reinforcing its focus on long-term value. Investors should watch Ark's combined ratio, Kudu's returns, and capital deployment.

A financial results roundup covers multiple insurers. HCI Group reported Q2 gross premiums earned of $321m and a 22.2% gross loss ratio, plus a completed $80m share buyback. Kingstone posted $15.5m net income and a 70.2% GAAP combined ratio. Kemper took a $460m goodwill impairment. Safety agreed to be acquired by Mapfre for about $1.54b at $105/share.

White Mountains Insurance Group reported Q2 2026 net income of $199.5m, or $80.58/share, on revenue of $844.6m, up from $689.2m a year earlier. Book value per share rose to $2,258 as of June 30. The company cited strong operating results, including Ark’s 84% combined ratio and MediaAlpha’s 35% share-price gain.

White Mountains Insurance Group (WTM) reported Q2 2026 net income attributable to common shareholders of $199.5 million, up from $122.9 million in Q2 2025. Total revenues were $844.6 million versus $689.2 million a year earlier. Book value per share rose to $2,258. The company repurchased 91,194 shares for $191 million and held 17.9 million MediaAlpha shares.

WHITE MOUNTAINS INSURANCE GROUP LTD (WTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONTACT: Rob Seelig (603) 640-2212 WHITE MOUNTAINS REPORTS SECOND QUARTER RESULTS HAMILTON, Bermuda (August 6, 2026) - White Mountains Insurance Group, Ltd. (NYSE: WTM) reported book value per share of $2,258 as of June 30, 2026, an increase of 4% for the second quar

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.